Kyverna Therapeutics (KYTX) Common Equity (2023 - 2026)
Kyverna Therapeutics (KYTX) reported Common Equity of $165.55 million for Q2 2026, down 10.2% from $184.38 million a year earlier and down 15.4% from the prior quarter.
Powered by 
Analysis
Kyverna Therapeutics (KYTX) Common Equity (2023 - 2026) Analysis & Trends
At the end of FY2025, Kyverna Therapeutics posted Common Equity of $232.28 million, down 12.9% from FY2024.
- By year, Common Equity came in at $266.59 million in FY2024 and -$13.14 million in FY2023.
- Five-year quarterly Common Equity spans a low of -$111.81 million in Q3 2023 and a high of $360.99 million in Q1 2024.
- Year over year, Common Equity has now declined in each of the last six quarters, with an average decline of 28.0% over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at $195.58 million (Q1 2026), $232.28 million (Q4 2025) and $151.95 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Kyverna Therapeutics | 419.91 Mn | 419.91 Mn | - | 165.55 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 165.55 Mn |
| Mar 31, 2026 | 195.58 Mn |
| Dec 31, 2025 | 232.28 Mn |
| Sep 30, 2025 | 151.95 Mn |
| Jun 30, 2025 | 184.38 Mn |
| Mar 31, 2025 | 224.01 Mn |
| Dec 31, 2024 | 266.59 Mn |
| Sep 30, 2024 | 302.71 Mn |
| Jun 30, 2024 | 333.51 Mn |
| Mar 31, 2024 | 360.99 Mn |
| Dec 31, 2023 | -13.14 Mn |
| Sep 30, 2023 | -111.81 Mn |
| Jun 30, 2023 | -97.20 Mn |
| Mar 31, 2023 | -84.61 Mn |
API Access
Kyverna Therapeutics Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=KYTX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "KYTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=KYTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();